Clinical trials recruiting for Gastroesophageal Adenocarcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BHB810 | 1 |
| DISP-10 | 1 |
| HH160 | 1 |
| Poly ICLC | 1 |
| Synthetic long peptide personalized cancer vaccine | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Ohio | 2 |
| California | 1 |
| Connecticut | 1 |
| Florida | 1 |
| Missouri | 1 |
| Tennessee | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
- Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels
Related conditions
Trials recruiting for Gastroesophageal Adenocarcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastroesophageal Adenocarcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.